Insider · CIK 0001587972

Crowley John J

Reports to the SEC for 3 companies · CHESHIRE

sec.gov

Transactions

Companies

Filings

CIK

0001587972

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−45K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−181K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−250K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−600K sh	—	—	0
2026-02-02	Centessa Pharmaceuticals plcA Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2026-02-02	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Financial Officer	AAward	+181K sh	—	—	181,000
2025-02-03	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2024-07-01	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Financial Officer	AAward	+600K sh	—	—	600,000
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−138K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−167K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−250K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10.4K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−313K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−63.7K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−106K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−38.6K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−27K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60.9K sh	—	—	0
2024-01-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+106K sh	—	—	106,100
2024-01-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+63.7K sh	—	—	63,700
2023-01-05	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2022-02-01	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+167K sh	—	—	167,000
2021-08-31	Fusion Pharmaceuticals Inc.A Award	Chief Financial Officer	AAward	+3,910 sh	—	—	10,410
2021-02-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+138K sh	—	—	138,000
2020-06-30	Fusion Pharmaceuticals Inc.P Purchase	Chief Financial Officer	PPurchase	+6,500 sh	$17.00	+$111K	6,500
2020-06-25	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60.9K sh	—	—	60,852
2020-06-25	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+27K sh	—	—	26,972
2020-02-06	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+38.6K sh	—	—	38,561
2016-10-01	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.F Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−284 sh	$83.34	−$23.7K	5,599
2016-05-24	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−1,913 sh	$85.00	−$163K	5,883
2016-05-24	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+1,000 sh	$46.62	+$46.6K	6,883
2016-05-24	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−913 sh	—	—	1,825
2016-05-24	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+913 sh	$59.41	+$54.2K	7,796
2016-05-24	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−1,000 sh	—	—	2,000
2016-02-28	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.F Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−76 sh	$73.70	−$5,601.2	5,883
2016-02-27	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.F Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−68 sh	$73.70	−$5,011.6	5,959
2016-02-26	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+5,360 sh	—	—	5,360
2016-02-26	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	SVP, Chief Accounting Officer	AAward	+1,093 sh	—	—	6,027
2015-10-01	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.F Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−285 sh	$63.52	−$18.1K	4,934
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−412 sh	$76.53	−$31.5K	5,319
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−100 sh	$76.53	−$7,653.4	5,219
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−912 sh	—	—	2,738
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−300 sh	$76.52	−$23K	5,731
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−100 sh	$76.52	−$7,652	6,031
2015-03-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	+912 sh	$59.41	+$54.2K	6,131
2015-02-28	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.F Tax Payment	SVP, Chief Accounting Officer	FTax Payment	−227 sh	$76.67	−$17.4K	5,219
2015-02-27	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)A Award	SVP, Chief Accounting Officer	AAward	+3,699 sh	—	—	3,699
2015-02-27	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.A Award	SVP, Chief Accounting Officer	AAward	+839 sh	—	—	5,446
2014-11-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.S Sale	SVP, Chief Accounting Officer	SSale	−900 sh	$64.00	−$57.6K	4,707
2014-11-04	CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Stock Options (Right to Buy)M Exercise/Conversion	SVP, Chief Accounting Officer	MExercise/Conversion	−1,000 sh	—	—	3,000

Recent filings

Accepted (ET)
Jun 244
Crowley John J0001470831-26-000620
SEC(opens sec.gov)
Feb 34
Crowley John J0001470831-26-000096
SEC(opens sec.gov)
Feb 44
Crowley John J0001847903-25-000029
SEC(opens sec.gov)
Jul 24
Crowley John J0001847903-24-000114
SEC(opens sec.gov)
Jun 44
Crowley John J0000950170-24-068893
SEC(opens sec.gov)
Jan 54
Crowley John J0000950170-24-002299
SEC(opens sec.gov)

Companies

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT